For The Better

With yet a third new Alzheimer’s drug expected to be approved by the Food and Drug Administration (FDA), the field is beginning to show progress in the fight to slow the disease.

With yet a third new Alzheimer’s drug expected to be approved by the Food and Drug Administration (FDA), the field is beginning to show progress in the fight to slow the disease.

Pharmaceutical scientists and biologists are teaming up to make the next generation of lipid nanoparticles (LNPs) for drug delivery. Combining structural biology with cutting edge pharmaceutical science, the team is designing LNPs that can precisely de…

Researchers are using DNA ‘origami’ templates to control the way viruses are assembled. The global team behind the research developed a way to direct the assembly of virus capsids — the protein shell of viruses — at physiological conditions in a prec…

Common bone density scans can detect a predictor of cardiovascular health risk — a process which can now be done a LOT faster.

ChatGPT’s responses to people’s healthcare-related queries are nearly indistinguishable from those provided by humans, a new study reveals, suggesting the potential for chatbots to be effective allies to healthcare providers’ communications with patients.

Giving patients with operable pancreatic cancers a three-pronged combination immunotherapy treatment consisting of the pancreatic cancer vaccine GVAX, the immune checkpoint therapy nivolumab and urelemab, an anti-CD137 agonist antibody treatment, is sa…